Singapore markets close in 5 hours 26 minutes

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3710+0.0007 (+0.19%)
At close: 04:00PM EDT
0.3597 -0.01 (-3.05%)
After hours: 07:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 57.01M
Enterprise value 41.70M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)28.79
Price/book (mrq)3.59
Enterprise value/revenue 21.17
Enterprise value/EBITDA -1.41

Trading information

Stock price history

Beta (5Y monthly) 1.00
52-week change 3-63.37%
S&P500 52-week change 3-5.62%
52-week high 31.4800
52-week low 30.3100
50-day moving average 30.4394
200-day moving average 30.5885

Share statistics

Avg vol (3-month) 3615.38k
Avg vol (10-day) 3692.83k
Shares outstanding 5149.98M
Implied shares outstanding 6N/A
Float 8148.2M
% held by insiders 11.07%
% held by institutions 18.70%
Shares short (14 Jul 2022) 45.62M
Short ratio (14 Jul 2022) 412.68
Short % of float (14 Jul 2022) 43.76%
Short % of shares outstanding (14 Jul 2022) 43.74%
Shares short (prior month 14 Jun 2022) 46.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:17
Last split date 312 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,713.76%

Management effectiveness

Return on assets (ttm)-37.95%
Return on equity (ttm)-87.00%

Income statement

Revenue (ttm)1.97M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-17.10%
Gross profit (ttm)-4.66M
EBITDA -32.31M
Net income avi to common (ttm)-30.93M
Diluted EPS (ttm)-0.2730
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)17.77M
Total cash per share (mrq)0.12
Total debt (mrq)2.61M
Total debt/equity (mrq)16.39
Current ratio (mrq)2.05
Book value per share (mrq)0.11

Cash flow statement

Operating cash flow (ttm)-39.87M
Levered free cash flow (ttm)-28.94M